we evaluated the safety and efficacy or oral enoxacin 400 mg versus intramuscular ceftriaxone 250 mg for the treatment of uncomplicated genital n. gonorrhoeae infections .
C0007561
ceftriaxone
C0018081
gonorrhoeae